Condition
Prurigo Nodularis (PN) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Prurigo Nodularis (PN) clinical trials that are recruiting, at sites in 6 countries (most in Netherlands (1), China (1), France (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Dupilumab for early and long-term symptom relief and immune changes in prurigo nodularis
This project will try dupilumab in adults with moderate-to-severe prurigo nodularis to see if it reduces itching and nodules and causes measurable immune changes over time.
-
ICP-332 for adults with prurigo nodularis
This will test whether ICP-332 can reduce severe itching and the nodules in adults with prurigo nodularis.
Related topics
Quick answers
How many Prurigo Nodularis (PN) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Netherlands (1 trial), China (1 trial), France (1 trial), Germany (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.